Introduction: Macrophage infiltration into adipose tissue and their polarization from an anti-inflammatory M2 to pro-inflammatory M1 phenotype contributes to adipose tissue inflammation and the development of insulin resistance. Androgen-dependent tissue factor pathway inhibitor-regulating protein (ADTRP) is a recently discovered enzyme that breaks down a class of anti-inflammatory and anti-diabetic lipids in adipose tissues. Our study aims to investigate the effect of ADTRP on macrophage polarization and migration to adipocytes.

Methods: Mouse 3T3-L1 mature adipocytes were either transduced with AAV-ADTRP viral vectors or transfected with ADTRP siRNA to overexpress or knockdown ADTRP respectively. Conditioned media from the ADTRP-overexpressed and ADTRP-knockdown adipocytes were collected and treated to mouse RAW 264.7 macrophages. Lipopolysaccharide (LPS) was used to induce a pro-inflammatory state in the macrophages. Gene expression of macrophage M1 and M2 markers, including IL-1β, IL-6, TNF-α, iNOS, CD206 and IL-10 were measured using RT-qPCR. Macrophage migration assay was performed by co-culturing RAW 264.7 macrophages and 3T3-L1 adipocytes in a transwell system.

Results: Conditioned media from ADTRP-overexpressed adipocytes reduced the expression of anti-inflammatory M2 macrophage markers, CD206 and IL-10. On the contrary, conditioned media from ADTRP-knockdown adipocytes increased M2 markers in basal-state macrophages and decreased pro-inflammatory M1 markers, including IL-1β, TNF-α and iNOS, in LPS-stimulated macrophages. We also observed reduced macrophage migration towards ADTRP-knockdown adipocytes.

Conclusion: ADTRP regulates macrophage polarization and migration to adipocytes. Inhibition of ADTRP can be further studied as a possible strategy to reduce adipose tissue inflammation.

Disclosure

S. Ong: None. C. Heng: None. Y. Lee: None. D. Ooi: None.

Funding

Khoo Teck Puat - National University Children's Medical Institute research grant

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.